Physical-chemical characterization of tungsten carbide nanoparticles as a basis for toxicological investigations

Nanotoxicology

Volumn 4, Issue 2, 2010, Pages 196-206

  Meißner, Tobias ^a   Kühnel, Dana ^b   Busch, Wibke ^b   Oswald, Steffen ^e   Richter, Volkmar ^a   Michaelis, Alexander ^a   Schirmer, Kristin ^c,d   Potthoff, Annegret ^a  

^a FRAUNHOFER INSTITUTE FOR CERAMIC TECHNOLOGIES AND SYSTEMS   (Germany)

^b HELMHOLTZ CENTRE FOR ENVIRONMENTAL RESEARCH UFZ   (Germany)

^c SWISS FEDERAL INSTITUTE OF AQUATIC SCIENCE AND TECHNOLOGY   (Switzerland)

^d ETH ZURICH   (Switzerland)

^e IFW DRESDEN   (Germany)

Author keywords

Nanoparticles; Particle characterization; Suspension preparation; Toxicity; Tungsten carbide

Indexed keywords

NANOPARTICLE; TUNGSTEN CARBIDE; TUNGSTEN DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL ANALYSIS; DISSOLUTION; ELECTROPHORETIC MOBILITY; LIGHT SCATTERING; NANOTECHNOLOGY; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; X RAY DIFFRACTION; X RAY PHOTOELECTRON SPECTROSCOPY; ZETA POTENTIAL;

ANIMALS; CATTLE; LIGHT; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; PARTICLE SIZE; POWDERS; SCATTERING, RADIATION; SERUM; SERUM ALBUMIN, BOVINE; SOLUBILITY; SONICATION; STATIC ELECTRICITY; SURFACE PROPERTIES; SUSPENSIONS; TOXICITY TESTS; TUNGSTEN COMPOUNDS; X-RAY DIFFRACTION;

BOVINAE;

EID: 77952794656     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.3109/17435391003605455     Document Type: Article

References (34)

1. Andersson KM, Bergström L. 2000. Oxidation and dissolution of tungsten carbide powder in water. Int J Refract Met Hard Mater 18(2):121-129.
2. Bastian S, Busch W, Kühnel D, Springer A, Meißner T, Holke R, Scholz S, Iwe M, Pompe W, Gelinsky M, Potthoff A, Richter V, Ikonomidou C, Schirmer K. 2009. Toxicity of tungsten carbide and cobalt-doped tungsten carbide nanoparticles in mammalian cells in vitro. Environ Health Perspect 117(4):530-536.
3. Borm P, Klaessig FC, Landry, TD, Moudgil B, Pauluhn J, Thomas K, Trottier R, Wood S. 2006. Research strategies for safety evaluation of nanomaterials, Part V: Role of dissolution in biological fate and effects of nanoscale particles. Toxicol Sci 90(1):23-32.
4. Deguchi S, Yamazaki T, Mukai S, Usami R, Horikoshi K. 2007. Stabilization of C60 nanoparticles by protein adsorption and its implications for toxicity studies. Chem Res Toxicol 20(6): 854-858.
5. Dutta D, Sundaram SK, Teeguarden JG, Riley BJ, Fifield LS, Jacobs JM, Addleman SR, Kaysen GA, Moudgil BM.Weber TJ. 2007. Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. Toxicol Sci 100(1): 303-315.
6. Griffitt RJ, Luo J, Gao J, Bonzongo JC, Barber DS. 2008. Effects of particle composition and species on toxicity of metallic nanomaterials in aquatic organisms. Environ Toxicol Chem 27(9):1972-1978.
7. Hildebrand H, Kühnel D, Potthoff A, Mackenzie K, Springer A, Schirmer K. 2009. Evaluating the cytotoxicity of palladium/ magnetite nano-catalysts intended for wastewater treatment. Environ Poll 158(1):65-73.
8. Hoet PH, Brüske-Hohlfeld I, Salata OV. 2004. Nanoparticles - known and unknown health risks. J Nanobiotechnol 2(1):12
9. ISO 14887:2000. Sample preparation - dispersing procedures for powders in liquids. International Organisation for Standardization
10. ISO 22412:2008. Particle size analysis - dynamic light scattering (DLS). International Organisation for Standardization
11. Jiang J, Oberdörster G, Elder A, Gelein R, Mercer P, Biswas P. 2008. Does nanoparticle activity depend upon size and crystal phase? Nanotoxicology 2(1):33-42.
12. Jiang J, Oberdörster G, Biswas P. 2009. Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies. J Nanopart Res 11(1):77-89.
13. Keller V, Cheval M, Vayer M, Ducros R, Maire G. 1991. Tungsten carbides as substitutes of platinoids in the heterogeneous catalysis I. The effect of surface composition on the reactivity of methlycyclopentane on tungsten carbides. Catal Lett 10(3):137-148.
14. Krug H, Klug P. 2007. Health and safety aspects of nanomaterials at the work place. Ceramic Forum Int 84:23-27.
15. Kühnel D, Busch W, Meißner T, Springer A, Potthoff A, Richter V, Gelinsky M, Schirmer K. 2009. Impact of exposure condition on the interaction of tungsten carbide and tungsten carbide cobalt nanoparticles with a rainbow trout gill cell line. Aquat Toxicol 93(2-3):91-99.
16. Li J, Li Q, Xu J, Li J, Cai X, Liu R, Li Y, Ma J, Li W. 2007. Comparative study on the acute pulmonary toxicity induced by 3 and 20 nm TiO2 primary particles in mice. Environ Toxicol Pharmacol 24(3) 239-244.
17. Limbach LK, Wick P, Manser P, Grass RN, Bruinink A, Stark, WJ. 2007. Exposure of engineered nanoparticles to human lung epithelial cells: Influence of chemical composition and catalytic activity on oxidative stress. Environ Sci Technol 41(11): 4158-4163.
18. Lin W, Xu Y, Huang CC, Ma Y, Shannon, KB, Chen DR, Huang YW. 2008. Toxicity of nano- and miro-sized ZnO particles in human lung epithelial cells. J Nanopart Res 11(1):25-39
19. Malvern Instruments Ltd. Zeta potential - an introduction in 30 minutes (KB000734). www.malvern.com
20. Mandzy N, Grulke E, Druffel T. 2005. Breakage of TiO2 agglomerates in electrostatically stabilized dispersions. Powder Technol 160(2):121-126.
21. Müller RH. 1996. Zetapotential und Partikelladung in der Laborpraxis. APV paperback series, vol.37. Wissenschaftliche Verlagsgesellschaft, Stuttgart.
22. Murdock RC, Braydich-Stolle L, Schrand AM, Schlager JJ, Hussain SM. 2008. Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicol Sci 101(2):239-253.
23. Navarro E, Piccapietra F, Wagner B, Marconi, F, Kaegi, R, Odzak N, Sigg L, Behra R. 2008. Toxicity of silver nanoparticles to Chlamydomonas reinhardtii. Environ Sci Technol 42(23): 8959-8964.
24. Nel A, Xia T, Mädler L, Li N. 2006. Toxic potential of materials at the nanolevel. Science 311:622-627.
25. National Institute of Standards (NIST). 2001. 960-963 NIST recommended practice guide. The use of nomenclature in dispersion science and technology. USA: NIST.
26. Oberdörster G, Oberdörster E, Oberdörster J. 2005. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113(7):823-839.
27. Potthoff A, Meißner T, Richter V, Busch W, Kühnel D, Bastian S, Iwe M, Springer A. 2009. Evaluation of health risks of nanoparticles - a contribution to a sustainable development of Nanotechnology. Solid State Phenomena 151:183-189.
28. Powers KW, Brown SC, Krishna VB, Wasdo SC, Moudgil BM, Roberts SM. 2006. Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. Toxicol Sci 90(2):296-303.
29. Schulze C, Kroll A, Lehr CM, Schäfer UF, Becker K, Schnekenburger J, Schulze Isfort C, Landsiedel R, Wohlleben W. 2008. Not ready to use - overcoming pitfalls when dispersing nanoparticles in physiological media. Nanotoxicology 2(2):51-61.
30. Stoeger T, Reinhard C, Takenaka S, Schroeppel A, Karg E, Ritter B, Heyder J, Schulz H. 2006. Instillation of six different ultrafine carbon particles indicates a surface area threshold dose for acute lung inflammation in mice. Environ Health Perspect 114(3):328-333.
31. Teeguarden JG, Hinderliter PM, Orr G, Thrall BD, Pounds JG. 2007. Particokinetics in vitro: Dosimetry considerations for in vitro nanoparticle toxicity assessments. Toxicol Sci 95(2): 300-312.
32. The Royal Society. 2004. Nanoscience and nanotechnologies: Opportunities and uncertainties. Accessed from the website: www.nanotec.org.uk/finalreport. htm.
33. Unfried K, Albrecht C, Klotz L-O, von Mikecz A, Grether-Beck S, Schins RPF. 2007. Cellular responses to nanoparticles: Target structures and mechanism. Nanotoxicology 1(1): 52-71.
34. Warheit DB. 2008. How meaningful are the results of nanotoxicity studies in the absence of adequate material characterization? Toxicol Sci 101(2):183-185.